Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrecto...
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
About this item
Full title
Author / Creator
Motzer, Robert J , Russo, Paul , Grünwald, Viktor , Tomita, Yoshihiko , Zurawski, Bogdan , Parikh, Omi , Buti, Sebastiano , Barthélémy, Philippe , Goh, Jeffrey C , Ye, Dingwei , Lingua, Alejo , Lattouf, Jean-Baptiste , Albigès, Laurence , George, Saby , Shuch, Brian , Sosman, Jeffrey , Staehler, Michael , Vázquez Estévez, Sergio , Simsek, Burcin , Spiridigliozzi, Julia , Chudnovsky, Aleksander and Bex, Axel
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Effective adjuvant therapy for patients with resected localised renal cell carcinoma represents an unmet need, with surveillance being the standard of care. We report results from part A of a phase 3, randomised trial that aimed to assess the efficacy and safety of adjuvant nivolumab plus ipilimumab versus placebo.
The double-blind, randomised,...
Alternative Titles
Full title
Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial
Authors, Artists and Contributors
Author / Creator
Russo, Paul
Grünwald, Viktor
Tomita, Yoshihiko
Zurawski, Bogdan
Parikh, Omi
Buti, Sebastiano
Barthélémy, Philippe
Goh, Jeffrey C
Ye, Dingwei
Lingua, Alejo
Lattouf, Jean-Baptiste
Albigès, Laurence
George, Saby
Shuch, Brian
Sosman, Jeffrey
Staehler, Michael
Vázquez Estévez, Sergio
Simsek, Burcin
Spiridigliozzi, Julia
Chudnovsky, Aleksander
Bex, Axel
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2775952592
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2775952592
Other Identifiers
ISSN
0140-6736,1474-547X
E-ISSN
1474-547X
DOI
10.1016/S0140-6736(22)02574-0
